Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms
Current Hematologic Malignancy Reports · 07.03.2026 · 21 (1)
DOI: 10.1007/s11899-026-00775-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Hematologic Malignancy Reports, online erschienen am 07.03.2026. Verfasst von Colette Hanna und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology, Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon. Hauptthemen laut MEDLINE: Hypereosinophilic Syndrome, Molecular Targeted Therapy, Myeloproliferative Disorders. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology/Oncology, Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon.
- Department of Diagnostic Radiology, American University of Beirut, Beirut, Lebanon.
- Division of Hematology and Oncology, Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
- Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada.
- Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. fhaddad@mdanderson.org.
Zitieren
APA
Hanna, C., Rizkallah, J., Charbel, N., Sakkal, S., & Haddad, F. G. (2026). Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms. Current Hematologic Malignancy Reports, 21(1). https://doi.org/10.1007/s11899-026-00775-4
Vancouver
Hanna C, Rizkallah J, Charbel N, Sakkal S, Haddad FG. Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms. Current Hematologic Malignancy Reports. 2026;21(1). doi:10.1007/s11899-026-00775-4
BibTeX
@article{Hanna2026,
author = {Hanna, Colette and Rizkallah, Joe and Charbel, Nicole and Sakkal, Shereen and Haddad, Fadi G},
title = {Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms},
journal = {Current Hematologic Malignancy Reports},
year = {2026},
volume = {21},
number = {1},
doi = {10.1007/s11899-026-00775-4}
}
EUVIMED